RESEARCH TRIANGLE PARK – Raleigh-based Merz North America has received approval from the U.S. Food and Drug Administration to market a treatment for blepharospasm, or involuntary blinking, in adults.
Dear Doctors: I’ve recently been diagnosed with benign essential blepharospasm. Would you please explain what this is? How serious is it? Does it spread? I know it’s not deadly, but I’ve read that it ...
RALEIGH, N.C.--(BUSINESS WIRE)--Merz Americas announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for XEOMIN ® ...
Tardive Dyskinesia is associated with certain prescription medications used to treat mental health or gastrointestinal conditions, and affects a broad range of people. It is characterized by mild to ...
Hosted on MSN
Do You Blink A Lot? Find Out What It Says About You
Blinking is a commonplace gesture. But when your eyes open and close at lightning speed, as if a speck of dust had settled in them, this tic takes on a whole new meaning. This natural, though ...
Tardive Dyskinesia or TD is associated with certain prescription medications used to treat mental health or gastrointestinal conditions, and affects a broad range of people. It is characterized by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback